Development of a gene therapy based bone marrow purging system for leukemias

Cancer Gene Therapy

Volumn 12, Issue 11, 2005, Pages 873-883

  Huang, Weitao ^a   Tan, Weihong ^a   Zhong, Qiu ^a   Schwarzenberger, Paul ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; Leukemia; Molecular conjugate vector; Stem cell purging; Suicide gene therapy

Indexed keywords

POLYLYSINE; VIRUS VECTOR;

ARTICLE; BONE MARROW; BONE MARROW PURGING; CELL KILLING; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIMIAN VIRUS 40; SUICIDE GENE; SUICIDE GENE THERAPY; TARGET CELL;

ANTIGENS, CD34; BONE MARROW PURGING; CELL SURVIVAL; GENE EXPRESSION PROFILING; GENE THERAPY; GENES, REPORTER; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; NEOPLASM CIRCULATING CELLS; POLYLYSINE; TRANSFECTION; TUMOR CELLS, CULTURED;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SIMIAN VIRUS 40; SIMPLEXVIRUS;

EID: 27144538619     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700848     Document Type: Article

References (34)

1. Forman SJ, Blume KG. Allogeneic bone marrow transplantation for acute leukemia. Hematol Oncol Clin N Am. 1990;4:517-533.
2. Zittoun RA, Mandelli F, Willemze R, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogeneous leukemia. N Engl J Med. 1994;332:217-223.
3. Drobyski WR, Ash RC, Casper JT, et al. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood. 1994;83:1980-1987.
4. Kolb HJ, Schmid C, Chen X, et al. Adoptive immunotherapy in chimeras with donor lymphocytes. Acta Haematol. 2003;110:110-120.
5. Gribben JG, Freedman AS, Neuberg D, et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med. 1991;325:1525-1533.
6. Miller CB, Rowlings PA, Zhang MJ, et al. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. Exp Hematol. 2001;29:1336-1346.
7. Feller N, Schuurhuis G, van der Pol M, et al. High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome. Leukemia. 2003;17:68-75.
8. Vescio R, Schiller G, Stewart AK, et al. Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood. 1999;93:1858-1868.
9. Chen L, Chen D, Manome Y, Dong Y, Fine HA, Kufe DW. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J Clin Invest. 1995;96:2775-2782.
10. Seth P, Brinkmann U, Schwartz GN, et al. Adenovirus mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging. Cancer Res. 1996;56:1346-1351.
11. Chen L, Pulsipher M, Chen D, et al. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest. 1996;98:2539-2548.
12. Schwarzenberger P, Huang W, Oliver P, Osidipe T, Theodossiou C, Kolls JK. Poly-L-lysine-based molecular conjugate vectors: a high efficiency gene transfer system for human progenitor and leukemia cells. Am J Med Sci. 2001;321:129-136.
13. Wattel E, Vanrumbeke M, Abina MA, et al. Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia. 1996;10:171-174.
14. Zhong Q, Oliver P, Huang W, et al. Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells. J Virol. 2001;75:10393-10400.
15. Gonzalez R, Vereecque R, Wickham TJ, et al. Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells. Hum Gene Ther. 1999;10:2709-2717.
16. Kolls J, Peppel K, Silvia M, Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene-transfer. PNAS-USA. 1994;91:215-219.
17. Smythe WR, Hwang HC, Amin KM, et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res. 1994;54:2055-2059.
18. Jones N, Shenk T. An adenovirus type 5 early gene function regulates expression of other early viral genes. PNAS USA. 1979;76:3665-3669.
19. Lei D, Lehmann M, Shellito JE, et al. Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats. Hum Gene Ther. 1996;7:2273-2279.
20. Schwarzenberger P, Hunt JD, Robert E, Theodossiou C, Kolls JK. Receptor-targeted recombinant adenovirus conglomerates: a novel molecular conjugate vector with improved expression characteristics. J Virol. 1997;71:8563-8571.
21. Schwarzenberger P, Kolls JK. Molecular conjugate vectors. In: Cid-Arreugi A, Garcia-Carranca A, eds. Viral Vectors. Natick, MA: Eaton; 2000: 171-189.
22. Beltinger C, Fulda S, Kammertoens T, Meyer E, Uckert W, Debatin KM. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc Natl Acad Sci USA. 1999;96:8699-8704.
23. Munshi N, Govindarajan R, Drake R, et al. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir. Blood. 1997;89:1334-1340.
24. Shibata MA, Morimoto J, Otsuki Y. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation. Cancer Gene Ther. 2002;9:16-27.
25. Zhong Q, Kolls JK, Schwarzenberger P. Retrovirus molecular conjugates. A novel, high transduction efficiency, potentially safety-improved, gene transfer system. J Biol Chem. 2001;276:24601-24607.
26. Schwarzenberger P, La Russa V, Miller A, et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol. 1998;161:6383-6389.
27. Schwarzenberger P, Spence SE, Gooya JM, Michiel DM, Ruscetti FW, Keller JR. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood. 1996;87:472-478.
28. Skutelsky E, Danon D. Redistribution of surface anionic sites on the luminalfront of blood vessel endothelium after interaction with polycationic ligand. J Cell Biol. 1976;71:232-241.
29. Wickham TJ, Roelvink PW, Brough DE, Kovesdi I. Adenovirus targeted to heparin-containing receptors increases its gene delivery efficiency to multiple cell types. Nat Biotechnol. 1996;14:1570-1573.
30. Zarrin AA, Malkin L, Fong I, Luk KD, Ghose A, Berinstein NL. Comparison of CMV, RSV, SV40 viral and Vlambda1 cellular promoters in B and T lymphoid and non-lymphoid cell lines. Biochim Biophys Acta. 1999;1446:135-139.
31. Goodell MA. Introduction: Focus on hematology. CD34(+) or CD34(-): does it really matter? Blood. 1999;94:2545-2547.
32. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. Human bone marrow CD34-cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol. 1998;26:353-360.
33. Brandt JE, Srour EF, van Besien K, Briddell RA, Hoffman R. Cytokine dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest. 1990;86:932-941.
34. Shpall EJ, Jones RB, Bearman SI. Transplantation of enriched CD34 positive autologous marrow into breast cancer patients following high dose chemotherapy: influence of CD34 positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol. 1994;12:28-36.